nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—GC—gall bladder—pancreatic cancer	0.0464	0.325	CbGeAlD
Calcitriol—GC—islet of Langerhans—pancreatic cancer	0.0304	0.213	CbGeAlD
Calcitriol—GC—pancreas—pancreatic cancer	0.0214	0.15	CbGeAlD
Calcitriol—GC—digestive system—pancreatic cancer	0.0183	0.128	CbGeAlD
Calcitriol—CYP24A1—digestive system—pancreatic cancer	0.0152	0.107	CbGeAlD
Calcitriol—CYP3A4—Tamoxifen—pancreatic cancer	0.0145	0.24	CbGbCtD
Calcitriol—CYP3A4—Erlotinib—pancreatic cancer	0.0123	0.204	CbGbCtD
Calcitriol—CYP3A4—Irinotecan—pancreatic cancer	0.0111	0.185	CbGbCtD
Calcitriol—VDR—digestive system—pancreatic cancer	0.00838	0.0586	CbGeAlD
Calcitriol—CYP3A4—Docetaxel—pancreatic cancer	0.00817	0.135	CbGbCtD
Calcitriol—CYP3A4—Sunitinib—pancreatic cancer	0.00813	0.135	CbGbCtD
Calcitriol—CYP3A4—Doxorubicin—pancreatic cancer	0.00609	0.101	CbGbCtD
Calcitriol—CYP3A4—digestive system—pancreatic cancer	0.0028	0.0196	CbGeAlD
Calcitriol—VDR—Nuclear Receptors—NR5A2—pancreatic cancer	0.00256	0.0906	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00202	0.0716	CbGpPWpGaD
Calcitriol—Blood urea increased—Epirubicin—pancreatic cancer	0.00179	0.00233	CcSEcCtD
Calcitriol—Decreased appetite—Tamoxifen—pancreatic cancer	0.00179	0.00233	CcSEcCtD
Calcitriol—Arrhythmia—Gemcitabine—pancreatic cancer	0.00178	0.00232	CcSEcCtD
Calcitriol—Decreased appetite—Erlotinib—pancreatic cancer	0.00177	0.0023	CcSEcCtD
Calcitriol—Pain—Tamoxifen—pancreatic cancer	0.00176	0.00229	CcSEcCtD
Calcitriol—Constipation—Tamoxifen—pancreatic cancer	0.00176	0.00229	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Doxorubicin—pancreatic cancer	0.00176	0.00229	CcSEcCtD
Calcitriol—Arrhythmia—Fluorouracil—pancreatic cancer	0.00175	0.00228	CcSEcCtD
Calcitriol—Constipation—Erlotinib—pancreatic cancer	0.00174	0.00227	CcSEcCtD
Calcitriol—Pain—Erlotinib—pancreatic cancer	0.00174	0.00227	CcSEcCtD
Calcitriol—Erythema—Gemcitabine—pancreatic cancer	0.00173	0.00226	CcSEcCtD
Calcitriol—Skin disorder—Sunitinib—pancreatic cancer	0.00171	0.00223	CcSEcCtD
Calcitriol—Erythema—Fluorouracil—pancreatic cancer	0.0017	0.00222	CcSEcCtD
Calcitriol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00168	0.00219	CcSEcCtD
Calcitriol—Anorexia—Sunitinib—pancreatic cancer	0.00168	0.00219	CcSEcCtD
Calcitriol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00167	0.00217	CcSEcCtD
Calcitriol—Blood urea increased—Doxorubicin—pancreatic cancer	0.00166	0.00216	CcSEcCtD
Calcitriol—Urticaria—Tamoxifen—pancreatic cancer	0.00164	0.00213	CcSEcCtD
Calcitriol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00163	0.00212	CcSEcCtD
Calcitriol—Body temperature increased—Erlotinib—pancreatic cancer	0.00161	0.0021	CcSEcCtD
Calcitriol—Abdominal pain—Erlotinib—pancreatic cancer	0.00161	0.0021	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00161	0.00209	CcSEcCtD
Calcitriol—Weight decreased—Docetaxel—pancreatic cancer	0.0016	0.00208	CcSEcCtD
Calcitriol—Insomnia—Sunitinib—pancreatic cancer	0.0016	0.00208	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.00158	0.00206	CcSEcCtD
Calcitriol—Hypertension—Irinotecan—pancreatic cancer	0.00154	0.002	CcSEcCtD
Calcitriol—Decreased appetite—Sunitinib—pancreatic cancer	0.00153	0.002	CcSEcCtD
Calcitriol—Conjunctivitis—Docetaxel—pancreatic cancer	0.00153	0.00199	CcSEcCtD
Calcitriol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00152	0.00197	CcSEcCtD
Calcitriol—Constipation—Sunitinib—pancreatic cancer	0.00151	0.00196	CcSEcCtD
Calcitriol—Pain—Sunitinib—pancreatic cancer	0.00151	0.00196	CcSEcCtD
Calcitriol—Discomfort—Irinotecan—pancreatic cancer	0.0015	0.00195	CcSEcCtD
Calcitriol—Hypertension—Gemcitabine—pancreatic cancer	0.0015	0.00195	CcSEcCtD
Calcitriol—Asthenia—Tamoxifen—pancreatic cancer	0.00148	0.00192	CcSEcCtD
Calcitriol—Convulsion—Fluorouracil—pancreatic cancer	0.00148	0.00192	CcSEcCtD
Calcitriol—Myalgia—Gemcitabine—pancreatic cancer	0.00148	0.00192	CcSEcCtD
Calcitriol—Chest pain—Gemcitabine—pancreatic cancer	0.00148	0.00192	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.00147	0.00191	CcSEcCtD
Calcitriol—Asthenia—Erlotinib—pancreatic cancer	0.00146	0.0019	CcSEcCtD
Calcitriol—Discomfort—Gemcitabine—pancreatic cancer	0.00146	0.0019	CcSEcCtD
Calcitriol—Pruritus—Tamoxifen—pancreatic cancer	0.00146	0.0019	CcSEcCtD
Calcitriol—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00145	0.00189	CcSEcCtD
Calcitriol—Myalgia—Fluorouracil—pancreatic cancer	0.00145	0.00189	CcSEcCtD
Calcitriol—Chest pain—Fluorouracil—pancreatic cancer	0.00145	0.00189	CcSEcCtD
Calcitriol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00144	0.00188	CcSEcCtD
Calcitriol—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00144	0.00188	CcSEcCtD
Calcitriol—Pruritus—Erlotinib—pancreatic cancer	0.00144	0.00188	CcSEcCtD
Calcitriol—Discomfort—Fluorouracil—pancreatic cancer	0.00143	0.00187	CcSEcCtD
Calcitriol—Haemoglobin—Docetaxel—pancreatic cancer	0.00142	0.00185	CcSEcCtD
Calcitriol—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00142	0.00184	CcSEcCtD
Calcitriol—Haemorrhage—Docetaxel—pancreatic cancer	0.00141	0.00184	CcSEcCtD
Calcitriol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00141	0.00183	CcSEcCtD
Calcitriol—Abdominal pain—Sunitinib—pancreatic cancer	0.00139	0.00181	CcSEcCtD
Calcitriol—Body temperature increased—Sunitinib—pancreatic cancer	0.00139	0.00181	CcSEcCtD
Calcitriol—Diarrhoea—Erlotinib—pancreatic cancer	0.00139	0.00181	CcSEcCtD
Calcitriol—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00139	0.00181	CcSEcCtD
Calcitriol—Anorexia—Irinotecan—pancreatic cancer	0.00138	0.0018	CcSEcCtD
Calcitriol—Pain in extremity—Epirubicin—pancreatic cancer	0.00138	0.00179	CcSEcCtD
Calcitriol—Skin disorder—Gemcitabine—pancreatic cancer	0.00137	0.00179	CcSEcCtD
Calcitriol—Anorexia—Gemcitabine—pancreatic cancer	0.00135	0.00176	CcSEcCtD
Calcitriol—Erythema multiforme—Docetaxel—pancreatic cancer	0.00134	0.00174	CcSEcCtD
Calcitriol—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00133	0.00174	CcSEcCtD
Calcitriol—Anorexia—Fluorouracil—pancreatic cancer	0.00133	0.00173	CcSEcCtD
Calcitriol—Insomnia—Irinotecan—pancreatic cancer	0.00131	0.00171	CcSEcCtD
Calcitriol—Vomiting—Tamoxifen—pancreatic cancer	0.00131	0.0017	CcSEcCtD
Calcitriol—Hypersensitivity—Sunitinib—pancreatic cancer	0.0013	0.00169	CcSEcCtD
Calcitriol—Rash—Tamoxifen—pancreatic cancer	0.0013	0.00169	CcSEcCtD
Calcitriol—Dermatitis—Tamoxifen—pancreatic cancer	0.0013	0.00169	CcSEcCtD
Calcitriol—Vomiting—Erlotinib—pancreatic cancer	0.0013	0.00169	CcSEcCtD
Calcitriol—Somnolence—Irinotecan—pancreatic cancer	0.00129	0.00168	CcSEcCtD
Calcitriol—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00129	0.00168	CcSEcCtD
Calcitriol—Headache—Tamoxifen—pancreatic cancer	0.00129	0.00168	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00129	0.00168	CcSEcCtD
Calcitriol—Rash—Erlotinib—pancreatic cancer	0.00128	0.00167	CcSEcCtD
Calcitriol—Dermatitis—Erlotinib—pancreatic cancer	0.00128	0.00167	CcSEcCtD
Calcitriol—Dehydration—Epirubicin—pancreatic cancer	0.00128	0.00167	CcSEcCtD
Calcitriol—Insomnia—Gemcitabine—pancreatic cancer	0.00128	0.00167	CcSEcCtD
Calcitriol—Headache—Erlotinib—pancreatic cancer	0.00128	0.00166	CcSEcCtD
Calcitriol—Pain in extremity—Doxorubicin—pancreatic cancer	0.00128	0.00166	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00127	0.00165	CcSEcCtD
Calcitriol—Asthenia—Sunitinib—pancreatic cancer	0.00127	0.00165	CcSEcCtD
Calcitriol—Decreased appetite—Irinotecan—pancreatic cancer	0.00126	0.00164	CcSEcCtD
Calcitriol—Arrhythmia—Docetaxel—pancreatic cancer	0.00126	0.00164	CcSEcCtD
Calcitriol—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00126	0.00164	CcSEcCtD
Calcitriol—Insomnia—Fluorouracil—pancreatic cancer	0.00126	0.00164	CcSEcCtD
Calcitriol—Somnolence—Gemcitabine—pancreatic cancer	0.00126	0.00164	CcSEcCtD
Calcitriol—Pruritus—Sunitinib—pancreatic cancer	0.00125	0.00162	CcSEcCtD
Calcitriol—Constipation—Irinotecan—pancreatic cancer	0.00124	0.00162	CcSEcCtD
Calcitriol—Pain—Irinotecan—pancreatic cancer	0.00124	0.00162	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00124	0.00162	CcSEcCtD
Calcitriol—Somnolence—Fluorouracil—pancreatic cancer	0.00124	0.00161	CcSEcCtD
Calcitriol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00123	0.0016	CcSEcCtD
Calcitriol—Erythema—Docetaxel—pancreatic cancer	0.00123	0.0016	CcSEcCtD
Calcitriol—Decreased appetite—Gemcitabine—pancreatic cancer	0.00123	0.0016	CcSEcCtD
Calcitriol—Nausea—Tamoxifen—pancreatic cancer	0.00122	0.00159	CcSEcCtD
Calcitriol—Constipation—Gemcitabine—pancreatic cancer	0.00121	0.00157	CcSEcCtD
Calcitriol—Pain—Gemcitabine—pancreatic cancer	0.00121	0.00157	CcSEcCtD
Calcitriol—Nausea—Erlotinib—pancreatic cancer	0.00121	0.00157	CcSEcCtD
Calcitriol—Decreased appetite—Fluorouracil—pancreatic cancer	0.00121	0.00157	CcSEcCtD
Calcitriol—Diarrhoea—Sunitinib—pancreatic cancer	0.00121	0.00157	CcSEcCtD
Calcitriol—Dysgeusia—Docetaxel—pancreatic cancer	0.00121	0.00157	CcSEcCtD
Calcitriol—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00119	0.00155	CcSEcCtD
Calcitriol—Pain—Fluorouracil—pancreatic cancer	0.00119	0.00155	CcSEcCtD
Calcitriol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00119	0.00155	CcSEcCtD
Calcitriol—Dehydration—Doxorubicin—pancreatic cancer	0.00119	0.00154	CcSEcCtD
Calcitriol—Pancreatitis—Epirubicin—pancreatic cancer	0.00117	0.00152	CcSEcCtD
Calcitriol—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00116	0.00152	CcSEcCtD
Calcitriol—Abdominal pain—Irinotecan—pancreatic cancer	0.00115	0.00149	CcSEcCtD
Calcitriol—Body temperature increased—Irinotecan—pancreatic cancer	0.00115	0.00149	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00115	0.00149	CcSEcCtD
Calcitriol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00114	0.00148	CcSEcCtD
Calcitriol—Vomiting—Sunitinib—pancreatic cancer	0.00112	0.00146	CcSEcCtD
Calcitriol—Body temperature increased—Gemcitabine—pancreatic cancer	0.00112	0.00146	CcSEcCtD
Calcitriol—Rash—Sunitinib—pancreatic cancer	0.00111	0.00145	CcSEcCtD
Calcitriol—Dermatitis—Sunitinib—pancreatic cancer	0.00111	0.00145	CcSEcCtD
Calcitriol—Urticaria—Fluorouracil—pancreatic cancer	0.00111	0.00144	CcSEcCtD
Calcitriol—Headache—Sunitinib—pancreatic cancer	0.0011	0.00144	CcSEcCtD
Calcitriol—Body temperature increased—Fluorouracil—pancreatic cancer	0.0011	0.00143	CcSEcCtD
Calcitriol—Pancreatitis—Doxorubicin—pancreatic cancer	0.00108	0.00141	CcSEcCtD
Calcitriol—Weight decreased—Epirubicin—pancreatic cancer	0.00108	0.0014	CcSEcCtD
Calcitriol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00107	0.00139	CcSEcCtD
Calcitriol—Convulsion—Docetaxel—pancreatic cancer	0.00107	0.00139	CcSEcCtD
Calcitriol—Hypertension—Docetaxel—pancreatic cancer	0.00106	0.00138	CcSEcCtD
Calcitriol—Drowsiness—Epirubicin—pancreatic cancer	0.00106	0.00138	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—SHH—pancreatic cancer	0.00106	0.0375	CbGpPWpGaD
Calcitriol—Chest pain—Docetaxel—pancreatic cancer	0.00105	0.00136	CcSEcCtD
Calcitriol—Myalgia—Docetaxel—pancreatic cancer	0.00105	0.00136	CcSEcCtD
Calcitriol—Nausea—Sunitinib—pancreatic cancer	0.00105	0.00136	CcSEcCtD
Calcitriol—Asthenia—Irinotecan—pancreatic cancer	0.00104	0.00136	CcSEcCtD
Calcitriol—Conjunctivitis—Epirubicin—pancreatic cancer	0.00103	0.00134	CcSEcCtD
Calcitriol—Urinary tract infection—Epirubicin—pancreatic cancer	0.00103	0.00134	CcSEcCtD
Calcitriol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00103	0.00133	CcSEcCtD
Calcitriol—Dry mouth—Docetaxel—pancreatic cancer	0.00102	0.00133	CcSEcCtD
Calcitriol—Asthenia—Gemcitabine—pancreatic cancer	0.00102	0.00132	CcSEcCtD
Calcitriol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.001	0.00131	CcSEcCtD
Calcitriol—Pruritus—Gemcitabine—pancreatic cancer	0.001	0.0013	CcSEcCtD
Calcitriol—Weight decreased—Doxorubicin—pancreatic cancer	0.000997	0.0013	CcSEcCtD
Calcitriol—Diarrhoea—Irinotecan—pancreatic cancer	0.000994	0.00129	CcSEcCtD
Calcitriol—Pruritus—Fluorouracil—pancreatic cancer	0.000984	0.00128	CcSEcCtD
Calcitriol—Drowsiness—Doxorubicin—pancreatic cancer	0.000983	0.00128	CcSEcCtD
Calcitriol—Skin disorder—Docetaxel—pancreatic cancer	0.000976	0.00127	CcSEcCtD
Calcitriol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000968	0.00126	CcSEcCtD
Calcitriol—Haemoglobin—Epirubicin—pancreatic cancer	0.000958	0.00125	CcSEcCtD
Calcitriol—Anorexia—Docetaxel—pancreatic cancer	0.000957	0.00125	CcSEcCtD
Calcitriol—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000955	0.00124	CcSEcCtD
Calcitriol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000955	0.00124	CcSEcCtD
Calcitriol—Haemorrhage—Epirubicin—pancreatic cancer	0.000953	0.00124	CcSEcCtD
Calcitriol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000952	0.00124	CcSEcCtD
Calcitriol—Vomiting—Irinotecan—pancreatic cancer	0.000924	0.0012	CcSEcCtD
Calcitriol—Rash—Irinotecan—pancreatic cancer	0.000916	0.00119	CcSEcCtD
Calcitriol—Dermatitis—Irinotecan—pancreatic cancer	0.000915	0.00119	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000915	0.00119	CcSEcCtD
Calcitriol—Headache—Irinotecan—pancreatic cancer	0.00091	0.00118	CcSEcCtD
Calcitriol—Insomnia—Docetaxel—pancreatic cancer	0.000908	0.00118	CcSEcCtD
Calcitriol—Erythema multiforme—Epirubicin—pancreatic cancer	0.000902	0.00117	CcSEcCtD
Calcitriol—Vomiting—Gemcitabine—pancreatic cancer	0.0009	0.00117	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—JAG1—pancreatic cancer	0.000899	0.0318	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—GADD45A—pancreatic cancer	0.000899	0.0318	CbGpPWpGaD
Calcitriol—Somnolence—Docetaxel—pancreatic cancer	0.000893	0.00116	CcSEcCtD
Calcitriol—Rash—Gemcitabine—pancreatic cancer	0.000892	0.00116	CcSEcCtD
Calcitriol—Dermatitis—Gemcitabine—pancreatic cancer	0.000891	0.00116	CcSEcCtD
Calcitriol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000887	0.00115	CcSEcCtD
Calcitriol—Headache—Gemcitabine—pancreatic cancer	0.000887	0.00115	CcSEcCtD
Calcitriol—Vomiting—Fluorouracil—pancreatic cancer	0.000885	0.00115	CcSEcCtD
Calcitriol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000882	0.00115	CcSEcCtD
Calcitriol—Rash—Fluorouracil—pancreatic cancer	0.000877	0.00114	CcSEcCtD
Calcitriol—Dermatitis—Fluorouracil—pancreatic cancer	0.000877	0.00114	CcSEcCtD
Calcitriol—Decreased appetite—Docetaxel—pancreatic cancer	0.000873	0.00114	CcSEcCtD
Calcitriol—Headache—Fluorouracil—pancreatic cancer	0.000872	0.00113	CcSEcCtD
Calcitriol—Nausea—Irinotecan—pancreatic cancer	0.000863	0.00112	CcSEcCtD
Calcitriol—Constipation—Docetaxel—pancreatic cancer	0.000859	0.00112	CcSEcCtD
Calcitriol—Pain—Docetaxel—pancreatic cancer	0.000859	0.00112	CcSEcCtD
Calcitriol—Arrhythmia—Epirubicin—pancreatic cancer	0.000852	0.00111	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.000842	0.0298	CbGpPWpGaD
Calcitriol—Nausea—Gemcitabine—pancreatic cancer	0.000841	0.00109	CcSEcCtD
Calcitriol—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000834	0.00109	CcSEcCtD
Calcitriol—Erythema—Epirubicin—pancreatic cancer	0.00083	0.00108	CcSEcCtD
Calcitriol—Nausea—Fluorouracil—pancreatic cancer	0.000827	0.00108	CcSEcCtD
Calcitriol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000821	0.00107	CcSEcCtD
Calcitriol—Dysgeusia—Epirubicin—pancreatic cancer	0.000813	0.00106	CcSEcCtD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000811	0.0287	CbGpPWpGaD
Calcitriol—Body temperature increased—Docetaxel—pancreatic cancer	0.000794	0.00103	CcSEcCtD
Calcitriol—Abdominal pain—Docetaxel—pancreatic cancer	0.000794	0.00103	CcSEcCtD
Calcitriol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000788	0.00103	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—pancreatic cancer	0.000778	0.0275	CbGpPWpGaD
Calcitriol—Erythema—Doxorubicin—pancreatic cancer	0.000768	0.000999	CcSEcCtD
Calcitriol—Agitation—Epirubicin—pancreatic cancer	0.000763	0.000993	CcSEcCtD
Calcitriol—Dysgeusia—Doxorubicin—pancreatic cancer	0.000752	0.000979	CcSEcCtD
Calcitriol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00074	0.000963	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—HES1—pancreatic cancer	0.000736	0.026	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—NDRG1—pancreatic cancer	0.000728	0.0257	CbGpPWpGaD
Calcitriol—Asthenia—Docetaxel—pancreatic cancer	0.000721	0.000938	CcSEcCtD
Calcitriol—Convulsion—Epirubicin—pancreatic cancer	0.000719	0.000936	CcSEcCtD
Calcitriol—Hypertension—Epirubicin—pancreatic cancer	0.000717	0.000933	CcSEcCtD
Calcitriol—Pruritus—Docetaxel—pancreatic cancer	0.000711	0.000925	CcSEcCtD
Calcitriol—Chest pain—Epirubicin—pancreatic cancer	0.000707	0.00092	CcSEcCtD
Calcitriol—Myalgia—Epirubicin—pancreatic cancer	0.000707	0.00092	CcSEcCtD
Calcitriol—Agitation—Doxorubicin—pancreatic cancer	0.000706	0.000918	CcSEcCtD
Calcitriol—Anxiety—Epirubicin—pancreatic cancer	0.000704	0.000916	CcSEcCtD
Calcitriol—Discomfort—Epirubicin—pancreatic cancer	0.000698	0.000909	CcSEcCtD
Calcitriol—Dry mouth—Epirubicin—pancreatic cancer	0.000691	0.000899	CcSEcCtD
Calcitriol—Diarrhoea—Docetaxel—pancreatic cancer	0.000687	0.000894	CcSEcCtD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000679	0.024	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000677	0.000882	CcSEcCtD
Calcitriol—Convulsion—Doxorubicin—pancreatic cancer	0.000665	0.000866	CcSEcCtD
Calcitriol—Hypertension—Doxorubicin—pancreatic cancer	0.000663	0.000863	CcSEcCtD
Calcitriol—Skin disorder—Epirubicin—pancreatic cancer	0.000658	0.000856	CcSEcCtD
Calcitriol—Myalgia—Doxorubicin—pancreatic cancer	0.000654	0.000851	CcSEcCtD
Calcitriol—Chest pain—Doxorubicin—pancreatic cancer	0.000654	0.000851	CcSEcCtD
Calcitriol—Anxiety—Doxorubicin—pancreatic cancer	0.000652	0.000848	CcSEcCtD
Calcitriol—Discomfort—Doxorubicin—pancreatic cancer	0.000646	0.000841	CcSEcCtD
Calcitriol—Anorexia—Epirubicin—pancreatic cancer	0.000646	0.00084	CcSEcCtD
Calcitriol—Dry mouth—Doxorubicin—pancreatic cancer	0.000639	0.000832	CcSEcCtD
Calcitriol—Vomiting—Docetaxel—pancreatic cancer	0.000639	0.000831	CcSEcCtD
Calcitriol—Rash—Docetaxel—pancreatic cancer	0.000633	0.000824	CcSEcCtD
Calcitriol—Dermatitis—Docetaxel—pancreatic cancer	0.000633	0.000823	CcSEcCtD
Calcitriol—Headache—Docetaxel—pancreatic cancer	0.000629	0.000819	CcSEcCtD
Calcitriol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000627	0.000816	CcSEcCtD
Calcitriol—VDR—Nuclear Receptors—PPARG—pancreatic cancer	0.000622	0.022	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TNFRSF10B—pancreatic cancer	0.000619	0.0219	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000617	0.000803	CcSEcCtD
Calcitriol—Insomnia—Epirubicin—pancreatic cancer	0.000613	0.000797	CcSEcCtD
Calcitriol—Skin disorder—Doxorubicin—pancreatic cancer	0.000609	0.000792	CcSEcCtD
Calcitriol—Somnolence—Epirubicin—pancreatic cancer	0.000602	0.000784	CcSEcCtD
Calcitriol—Anorexia—Doxorubicin—pancreatic cancer	0.000597	0.000777	CcSEcCtD
Calcitriol—Nausea—Docetaxel—pancreatic cancer	0.000597	0.000776	CcSEcCtD
Calcitriol—Decreased appetite—Epirubicin—pancreatic cancer	0.000589	0.000766	CcSEcCtD
Calcitriol—Pain—Epirubicin—pancreatic cancer	0.000579	0.000754	CcSEcCtD
Calcitriol—Constipation—Epirubicin—pancreatic cancer	0.000579	0.000754	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000571	0.000743	CcSEcCtD
Calcitriol—Insomnia—Doxorubicin—pancreatic cancer	0.000567	0.000738	CcSEcCtD
Calcitriol—Somnolence—Doxorubicin—pancreatic cancer	0.000557	0.000725	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—pancreatic cancer	0.000556	0.0197	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000554	0.000721	CcSEcCtD
Calcitriol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000545	0.000709	CcSEcCtD
Calcitriol—Urticaria—Epirubicin—pancreatic cancer	0.000538	0.0007	CcSEcCtD
Calcitriol—Constipation—Doxorubicin—pancreatic cancer	0.000536	0.000698	CcSEcCtD
Calcitriol—Pain—Doxorubicin—pancreatic cancer	0.000536	0.000698	CcSEcCtD
Calcitriol—Body temperature increased—Epirubicin—pancreatic cancer	0.000535	0.000697	CcSEcCtD
Calcitriol—Abdominal pain—Epirubicin—pancreatic cancer	0.000535	0.000697	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—TGFA—pancreatic cancer	0.000526	0.0186	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000513	0.000667	CcSEcCtD
Calcitriol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000499	0.000649	CcSEcCtD
Calcitriol—Urticaria—Doxorubicin—pancreatic cancer	0.000498	0.000648	CcSEcCtD
Calcitriol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000495	0.000645	CcSEcCtD
Calcitriol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000495	0.000645	CcSEcCtD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000491	0.0174	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000488	0.0173	CbGpPWpGaD
Calcitriol—Asthenia—Epirubicin—pancreatic cancer	0.000486	0.000632	CcSEcCtD
Calcitriol—Pruritus—Epirubicin—pancreatic cancer	0.000479	0.000624	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.000479	0.0169	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—HSPA1B—pancreatic cancer	0.000469	0.0166	CbGpPWpGaD
Calcitriol—Diarrhoea—Epirubicin—pancreatic cancer	0.000463	0.000603	CcSEcCtD
Calcitriol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000462	0.000601	CcSEcCtD
Calcitriol—Asthenia—Doxorubicin—pancreatic cancer	0.00045	0.000585	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.000447	0.0158	CbGpPWpGaD
Calcitriol—Pruritus—Doxorubicin—pancreatic cancer	0.000443	0.000577	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—pancreatic cancer	0.000441	0.0156	CbGpPWpGaD
Calcitriol—Vomiting—Epirubicin—pancreatic cancer	0.000431	0.00056	CcSEcCtD
Calcitriol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000429	0.000558	CcSEcCtD
Calcitriol—Rash—Epirubicin—pancreatic cancer	0.000427	0.000556	CcSEcCtD
Calcitriol—Dermatitis—Epirubicin—pancreatic cancer	0.000427	0.000555	CcSEcCtD
Calcitriol—Headache—Epirubicin—pancreatic cancer	0.000424	0.000552	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—GADD45A—pancreatic cancer	0.00042	0.0148	CbGpPWpGaD
Calcitriol—Nausea—Epirubicin—pancreatic cancer	0.000402	0.000524	CcSEcCtD
Calcitriol—Vomiting—Doxorubicin—pancreatic cancer	0.000399	0.000519	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—HSPA1A—pancreatic cancer	0.000396	0.014	CbGpPWpGaD
Calcitriol—Rash—Doxorubicin—pancreatic cancer	0.000395	0.000514	CcSEcCtD
Calcitriol—Dermatitis—Doxorubicin—pancreatic cancer	0.000395	0.000514	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—pancreatic cancer	0.000395	0.014	CbGpPWpGaD
Calcitriol—Headache—Doxorubicin—pancreatic cancer	0.000393	0.000511	CcSEcCtD
Calcitriol—Nausea—Doxorubicin—pancreatic cancer	0.000372	0.000484	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00035	0.0124	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.000297	0.0105	CbGpPWpGaD
Calcitriol—GC—Metabolism—PRSS1—pancreatic cancer	0.000293	0.0104	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—BCL2L1—pancreatic cancer	0.000259	0.00914	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TSC2—pancreatic cancer	0.000257	0.00909	CbGpPWpGaD
Calcitriol—GC—Metabolism—ARG2—pancreatic cancer	0.000254	0.00898	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MET—pancreatic cancer	0.000241	0.00853	CbGpPWpGaD
Calcitriol—GC—Metabolism—TYMP—pancreatic cancer	0.000222	0.00784	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—RB1—pancreatic cancer	0.00021	0.00741	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MMP2—pancreatic cancer	0.000201	0.00711	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—CHD3—pancreatic cancer	0.000201	0.00711	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000201	0.00711	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000193	0.00684	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.00019	0.00674	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000183	0.00647	CbGpPWpGaD
Calcitriol—GC—Metabolism—GLP1R—pancreatic cancer	0.000179	0.00632	CbGpPWpGaD
Calcitriol—GC—Metabolism—DPYD—pancreatic cancer	0.000176	0.00622	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NR5A2—pancreatic cancer	0.000168	0.00596	CbGpPWpGaD
Calcitriol—GC—Metabolism—SLC2A2—pancreatic cancer	0.000167	0.0059	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000165	0.00584	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000162	0.00573	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000159	0.00564	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PRSS1—pancreatic cancer	0.000156	0.00553	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PTEN—pancreatic cancer	0.00015	0.00531	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000145	0.00514	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ARG2—pancreatic cancer	0.000135	0.00479	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000134	0.00474	CbGpPWpGaD
Calcitriol—GC—Metabolism—CD44—pancreatic cancer	0.000129	0.00457	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000127	0.00448	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000125	0.00444	CbGpPWpGaD
Calcitriol—GC—Metabolism—GCG—pancreatic cancer	0.000124	0.00438	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—EGFR—pancreatic cancer	0.000122	0.00432	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000122	0.00431	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—TYMP—pancreatic cancer	0.000118	0.00419	CbGpPWpGaD
Calcitriol—GC—Metabolism—STK11—pancreatic cancer	0.000116	0.00412	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000109	0.00387	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000105	0.00372	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP53—pancreatic cancer	0.000103	0.00363	CbGpPWpGaD
Calcitriol—GC—Metabolism—TYMS—pancreatic cancer	0.0001	0.00354	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.77e-05	0.00346	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MEN1—pancreatic cancer	9.67e-05	0.00342	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GLP1R—pancreatic cancer	9.54e-05	0.00338	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—DPYD—pancreatic cancer	9.39e-05	0.00332	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH4—pancreatic cancer	9.17e-05	0.00324	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	8.99e-05	0.00318	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC2A2—pancreatic cancer	8.91e-05	0.00315	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.82e-05	0.00312	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—HSPA1B—pancreatic cancer	8.75e-05	0.00309	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.51e-05	0.00301	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—PPARG—pancreatic cancer	8.48e-05	0.003	CbGpPWpGaD
Calcitriol—GC—Metabolism—APOE—pancreatic cancer	8.15e-05	0.00288	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—EZH2—pancreatic cancer	7.96e-05	0.00282	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH3—pancreatic cancer	7.8e-05	0.00276	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.75e-05	0.00274	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.71e-05	0.00273	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—HSPA1A—pancreatic cancer	7.38e-05	0.00261	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CG—pancreatic cancer	7.35e-05	0.0026	CbGpPWpGaD
Calcitriol—GC—Metabolism—PPARG—pancreatic cancer	7.1e-05	0.00251	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CD44—pancreatic cancer	6.9e-05	0.00244	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.76e-05	0.00239	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.7e-05	0.00237	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GCG—pancreatic cancer	6.62e-05	0.00234	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CD—pancreatic cancer	6.47e-05	0.00229	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—STK11—pancreatic cancer	6.22e-05	0.0022	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SMAD4—pancreatic cancer	5.87e-05	0.00208	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.84e-05	0.00207	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CB—pancreatic cancer	5.64e-05	0.00199	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTGS2—pancreatic cancer	5.58e-05	0.00198	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—TYMS—pancreatic cancer	5.35e-05	0.00189	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTEN—pancreatic cancer	4.87e-05	0.00172	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—pancreatic cancer	4.84e-05	0.00171	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—APOE—pancreatic cancer	4.35e-05	0.00154	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH1—pancreatic cancer	4.33e-05	0.00153	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.12e-05	0.00146	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPARG—pancreatic cancer	4.08e-05	0.00145	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CG—pancreatic cancer	3.93e-05	0.00139	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPARG—pancreatic cancer	3.79e-05	0.00134	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CD—pancreatic cancer	3.45e-05	0.00122	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—pancreatic cancer	3.44e-05	0.00122	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CB—pancreatic cancer	3.01e-05	0.00106	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS2—pancreatic cancer	2.98e-05	0.00105	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKT1—pancreatic cancer	2.81e-05	0.000993	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTEN—pancreatic cancer	2.6e-05	0.00092	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—pancreatic cancer	2.33e-05	0.000824	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.03e-05	0.000717	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—pancreatic cancer	1.83e-05	0.000649	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.76e-05	0.000622	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—AKT1—pancreatic cancer	1.62e-05	0.000571	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.54e-05	0.000544	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKT1—pancreatic cancer	1.5e-05	0.00053	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.24e-05	0.000438	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.22e-05	0.000431	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.16e-05	0.000409	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CD44—pancreatic cancer	8.95e-06	0.000317	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GCG—pancreatic cancer	8.59e-06	0.000304	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—STK11—pancreatic cancer	8.07e-06	0.000286	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.94e-06	0.000246	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—APOE—pancreatic cancer	5.65e-06	0.0002	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.1e-06	0.00018	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.92e-06	0.000174	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.48e-06	0.000158	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.91e-06	0.000138	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.87e-06	0.000137	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.37e-06	0.000119	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.38e-06	8.42e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.94e-06	6.88e-05	CbGpPWpGaD
